查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1411705

數位生物標記市場：按類型、治療領域、最終用途分類 - 2024-2030 年全球預測

Digital Biomarkers Market by Type (Hardware, Software), Therapeutic Area (Cardiovascular and metabolic disorders (CVMD), Musculoskeletal disorders, Neurological disorders), End-Use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年數位生物標記市場規模為36.3億美元，2024年將達43.4億美元，2030年將達到130億美元，複合年成長率為19.97%。

數位生物標記的全球市場

主要市場統計
基準年[2023] 36.3億美元
預測年份 [2024] 43.4億美元
預測年份 [2030] 130億美元
複合年成長率（%） 19.97%
數位生物標記市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估數位生物標記市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對數位生物標記市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-數位生物標記物市場的市場規模和預測是多少？

2-在數位生物標記市場的預測期內，需要考慮投資哪些產品、細分市場、應用和領域？

3-數位生物標記市場的技術趨勢和法律規範是什麼？

4-數位生物標記市場主要供應商的市場佔有率是多少？

5-進入數位生物標記市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 在慢性病治療中增加生物標記檢測的使用
      • 數位生物標記診斷的主要好處
      • 數位生物標記在以病人為中心的藥物開發和精準醫療的應用
    • 抑制因素
      • 與生物標記物開發和數位生物標記物採用相關的高成本
    • 機會
      • 數位生物標記的最新進展提高了彈性和定製配置
      • 政府對遠端醫療基礎設施的投資
    • 任務
      • 與資料檢驗和解釋相關的問題
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章數位生物標記市場：按類型

  • 硬體
    • 感應器
    • 穿戴式裝置
  • 軟體

第 7 章按治療領域分類的數位生物標記市場

  • 心血管和代謝疾病（CVMD）
  • 肌肉骨骼疾病
  • 神經系統疾病
  • 精神障礙
  • 呼吸系統疾病
  • 睡眠和運動障礙

第8章數位生物標記市場：依最終用途

  • 醫療保健消費者
  • 醫療服務提供方

第9章美洲數位生物標記市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區數位生物標記市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的數位生物標記市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：按主要企業分類
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • ActiGraph, LLC
    • Adherium
    • Akili, Inc.
    • Altoida, Inc.
    • Amgen Inc.
    • Aural Analytics, Inc.
    • Biofourmis Pte. Ltd.
    • Biogen Inc.
    • Brainomix
    • Chugai Pharmaceutical Co., Ltd.
    • Clarigent Health
    • Eli Lilly and Company
    • Empatica Inc.
    • F. Hoffmann-La Roche Ltd.
    • Feel Therapeutics
    • GERO PTE. LTD.
    • Huma Therapeutics Limited
    • IXICO PLC
    • Kinsa Inc.
    • Koneksa Health
    • Medable Inc.
    • Owkin, Inc.
    • Sidekick Health ehf.
    • Verily Life Sciences
    • VivoSense, Inc
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-5C6F41F5AF53

[192 Pages Report] The Digital Biomarkers Market size was estimated at USD 3.63 billion in 2023 and expected to reach USD 4.34 billion in 2024, at a CAGR 19.97% to reach USD 13.00 billion by 2030.

Global Digital Biomarkers Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.63 billion
Estimated Year [2024] USD 4.34 billion
Forecast Year [2030] USD 13.00 billion
CAGR (%) 19.97%
Digital Biomarkers Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Digital Biomarkers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital Biomarkers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Digital Biomarkers Market, highlighting leading vendors and their innovative profiles. These include ActiGraph, LLC, Adherium, Akili, Inc., Altoida, Inc., Amgen Inc., Aural Analytics, Inc., Biofourmis Pte. Ltd., Biogen Inc., Brainomix, Chugai Pharmaceutical Co., Ltd., Clarigent Health, Eli Lilly and Company, Empatica Inc., F. Hoffmann-La Roche Ltd., Feel Therapeutics, GERO PTE. LTD., Huma Therapeutics Limited, IXICO PLC, Kinsa Inc., Koneksa Health, Medable Inc., Owkin, Inc., Sidekick Health ehf., Verily Life Sciences, and VivoSense, Inc.

Market Segmentation & Coverage

This research report categorizes the Digital Biomarkers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Hardware
      • Sensor
      • Wearable Device
    • Software
  • Therapeutic Area
    • Cardiovascular and metabolic disorders (CVMD)
    • Musculoskeletal disorders
    • Neurological disorders
    • Psychiatric Disorders
    • Respiratory Disorders
    • Sleep & Movement Disease
  • End-Use
    • Healthcare Consumers
    • Healthcare Providers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Digital Biomarkers Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital Biomarkers Market?

3. What are the technology trends and regulatory frameworks in the Digital Biomarkers Market?

4. What is the market share of the leading vendors in the Digital Biomarkers Market?

5. Which modes and strategic moves are suitable for entering the Digital Biomarkers Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Digital Biomarkers Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing usage of biomarkers testing for the treatment of chronic diseases
      • 5.1.1.2. Significant benefits of digital biomarkers diagnosis
      • 5.1.1.3. Applications of digital biomarkers in patient-focused drug development and precision medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with biomarkers development and adoption of digital biomarkers
    • 5.1.3. Opportunities
      • 5.1.3.1. Recent advancements in digital biomarkers for more flexibility and customized configuration
      • 5.1.3.2. Government investment in telehealth infrastructure
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with data validation and interpretation
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Digital Biomarkers Market, by Type

  • 6.1. Introduction
  • 6.2. Hardware
    • 6.3.1. Sensor
    • 6.3.2. Wearable Device
  • 6.3. Software

7. Digital Biomarkers Market, by Therapeutic Area

  • 7.1. Introduction
  • 7.2. Cardiovascular and metabolic disorders (CVMD)
  • 7.3. Musculoskeletal disorders
  • 7.4. Neurological disorders
  • 7.5. Psychiatric Disorders
  • 7.6. Respiratory Disorders
  • 7.7. Sleep & Movement Disease

8. Digital Biomarkers Market, by End-Use

  • 8.1. Introduction
  • 8.2. Healthcare Consumers
  • 8.3. Healthcare Providers

9. Americas Digital Biomarkers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Digital Biomarkers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Digital Biomarkers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. ActiGraph, LLC
    • 13.1.2. Adherium
    • 13.1.3. Akili, Inc.
    • 13.1.4. Altoida, Inc.
    • 13.1.5. Amgen Inc.
    • 13.1.6. Aural Analytics, Inc.
    • 13.1.7. Biofourmis Pte. Ltd.
    • 13.1.8. Biogen Inc.
    • 13.1.9. Brainomix
    • 13.1.10. Chugai Pharmaceutical Co., Ltd.
    • 13.1.11. Clarigent Health
    • 13.1.12. Eli Lilly and Company
    • 13.1.13. Empatica Inc.
    • 13.1.14. F. Hoffmann-La Roche Ltd.
    • 13.1.15. Feel Therapeutics
    • 13.1.16. GERO PTE. LTD.
    • 13.1.17. Huma Therapeutics Limited
    • 13.1.18. IXICO PLC
    • 13.1.19. Kinsa Inc.
    • 13.1.20. Koneksa Health
    • 13.1.21. Medable Inc.
    • 13.1.22. Owkin, Inc.
    • 13.1.23. Sidekick Health ehf.
    • 13.1.24. Verily Life Sciences
    • 13.1.25. VivoSense, Inc
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DIGITAL BIOMARKERS MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL BIOMARKERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. DIGITAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DIGITAL BIOMARKERS MARKET DYNAMICS
  • FIGURE 7. DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 10. DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. DIGITAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. DIGITAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL BIOMARKERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. DIGITAL BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL BIOMARKERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 8. DIGITAL BIOMARKERS MARKET SIZE, BY SENSOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DIGITAL BIOMARKERS MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DIGITAL BIOMARKERS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 12. DIGITAL BIOMARKERS MARKET SIZE, BY CARDIOVASCULAR AND METABOLIC DISORDERS (CVMD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DIGITAL BIOMARKERS MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DIGITAL BIOMARKERS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DIGITAL BIOMARKERS MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DIGITAL BIOMARKERS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DIGITAL BIOMARKERS MARKET SIZE, BY SLEEP & MOVEMENT DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. DIGITAL BIOMARKERS MARKET SIZE, BY HEALTHCARE CONSUMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DIGITAL BIOMARKERS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DIGITAL BIOMARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY HARDWARE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DIGITAL BIOMARKERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. DIGITAL BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 190. DIGITAL BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. DIGITAL BIOMARKERS MARKET LICENSE & PRICING